Key result
Transcatheter device closure is a safe and effective therapy for the majority of older infants and children with patent ductus arteriosus, with numerous devices developed over the past four decades.
Transcatheter device closure is a safe and effective outpatient procedure for the majority of older infants and children with patent ductus arteriosus.
Answers are grounded in this paper and cite their sources.
May support outpatient transcatheter PDA closure in older infants and children; leaves open device-specific durability and long-term outcomes.
Patent ductus arteriosus (PDA) is one of the most common congenital heart defects. Although surgery is still required in symptomatic neonates, the majority of older infants and children can undergo safe and effective transcatheter device closure on an out-patient basis. First described in 1967, over the past four decades, numerous devices have been specifically developed for this purpose. This article will review the current status of transcatheter therapy. The experience with each device is detailed and issues and controversies are reviewed.
No takes yet. Share an insight, caveat, or question.
Jennifer Rutledge (2003) conducted a review in Patent ductus arteriosus. Transcatheter device closure was evaluated. Transcatheter device closure is a safe and effective therapy for the majority of older infants and children with patent ductus arteriosus, with numerous devices developed over the past four decades.
Synapse has enriched 10 related papers. Consider them for comparative context: